TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million

Bulletin Express

06/25

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.

The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.

Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.

The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1160040228"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160040228\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160040228?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160040228","market":"us","top_or_hot":-1,"title":"TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.</p>\n<p>The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.</p>\n<p>Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.</p>\n<p>The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED repurchases 43,100 A-shares; outstanding share count trimmed to 711.05 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-25 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.</p>\n<p>The repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.</p>\n<p>Following the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.</p>\n<p>The company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1160040228","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160040228","pubTimestamp":1782377175,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange. The repurchase was executed within a price range of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药回购4.31万股A股；流通股数量削减至7.1105亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed that it bought back 43,100 A-shares on 25 June 2026 via the Shenzhen Stock Exchange.\nThe repurchase was executed within a price range of RMB 42.44–42.78 per share, representing a volume-weighted average repurchase cost of approximately RMB 42.65 per share. Aggregate consideration amounted to about RMB 1.84 million.\nFollowing the transaction, TIGERMED’s issued share capital (excluding treasury shares) declined by 0.0061 % to 711.05 million shares. Concurrently, the company’s treasury stock rose to 26.85 million shares. The total number of issued shares remains unchanged at 737.90 million because the repurchased shares are being held in treasury and have not been cancelled.\nThe company confirmed that the buyback complied with Shenzhen Stock Exchange regulations and the relevant Hong Kong Stock Exchange rules governing share repurchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}